Search results for the GEO ID: GSE39354
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM966522
GPL570
VCaP-siControl-EtOH-A VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH VCaP cells transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966523
GPL570
VCaP-siControl-EtOH-B VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH VCaP cells transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966524
GPL570
VCaP-siControl-EtOH-C VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH VCaP cells transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966525
GPL570
VCaP-siERG-EtOH-A VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of EtOH VCaP cells transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966526
GPL570
VCaP-siERG-EtOH-B VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of EtOH VCaP cells transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966527
GPL570
VCaP-siERG-EtOH-C VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of EtOH VCaP cells transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966528
GPL570
VCaP-siControl-DHT-A VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT VCaP cells transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966529
GPL570
VCaP-siControl-DHT-B VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT VCaP cells transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966530
GPL570
VCaP-siControl-DHT-C VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT VCaP cells transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966532
GPL570
VCaP-siERG-DHT-B VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT VCaP cells transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966533
GPL570
VCaP-siERG-DHT-C VCaP cells cell line: VCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT VCaP cells transfected with siERG were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966534
GPL570
LNCaP-shControl-EtOH-A LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH LNCaP cells transfected with shControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966535
GPL570
LNCaP-shControl-EtOH-B LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH LNCaP cells transfected with shControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966536
GPL570
LNCaP-shControl-EtOH-C LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH LNCaP cells transfected with shControl were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966537
GPL570
LNCaP-shETV1-EtOH-A LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of EtOH LNCaP cells transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966538
GPL570
LNCaP-shETV1-EtOH-B LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of EtOH LNCaP cells transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966539
GPL570
LNCaP-shETV1-EtOH-C LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of EtOH LNCaP cells transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of EtOH (vehicle)
GSM966540
GPL570
LNCaP-shControl-DHT-A LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT LNCaP cells transfected with shControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966541
GPL570
LNCaP-shControl-DHT-B LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT LNCaP cells transfected with shControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966542
GPL570
LNCaP-shControl-DHT-C LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with siControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT LNCaP cells transfected with shControl were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966543
GPL570
LNCaP-shETV1-DHT-A LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT LNCaP cells transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966544
GPL570
LNCaP-shETV1-DHT-B LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT LNCaP cells transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
GSM966545
GPL570
LNCaP-shETV1-DHT-C LNCaP cells cell line: LNCaP tissue: prostate tumor stage: androgen-dependent cancer cell treatment: transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT LNCaP cells transfected with shETV1 were grown in androgen deprived serum for 2 days and then in the presence of 10nM DHT
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes